Shree Ram Proteins
SRPL NSE
Shree Ram Proteins
Fast Moving Consumer GoodsNSE: SRPL Agricultural Food & other Products
Key Fundamentals
MicrocapFMCG ProductsFMCGMarket Cap
₹14.57 Cr
P/E Ratio
-0.6
EBITDA
₹-16.90 Cr
Return on Equity
-82.72%
Debt to Equity
2.47
Book Value
₹0.87
52W High
₹0.84
52W Low
₹0.32
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.95 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- Promoter holding is low: 4.08%
- Company has a low return on equity of -32.6% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -16.6%
Growth Rate
Revenue Growth
-82.78% lower than
3Y
Net Income Growth
120% higher than
3Y
Cash Flow Change
259% higher than
3Y
ROE
301% higher than
3Y
ROCE
196% higher than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.11 | 5.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 7.66 | 7.48 | 4.55 | 3.29 | 0.25 | 0.3 | 0.18 | 0.18 | 1.69 | 0.11 | 0.18 | 2.49 | 0.46 |
| Operating Profit | 1.45 | -1.82 | -4.55 | -3.29 | -0.25 | -0.3 | -0.18 | -0.18 | -1.69 | -0.11 | -0.18 | -2.49 | -0.46 |
| OPM % | 15.92% | -32.16% | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0.1 | 0.23 | 0 | 0.01 | 0 | -7.89 | -4.15 | -3.99 | 0.01 | -4.72 | 0 | 0.01 | 1.4 |
| Interest | 1.06 | 0.36 | 0.01 | 0 | 0 | 3.38 | 0.02 | 0 | 0 | 0.01 | 0 | 0 | 7.21 |
| Depreciation | 0.21 | 0.21 | 0.21 | 0.21 | 0.17 | 0.03 | 0.31 | 0.17 | 0.14 | 0.14 | 0.14 | 0.14 | 0.09 |
| PBT | 0.28 | -2.16 | -4.77 | -3.49 | -0.42 | -11.6 | -4.66 | -4.34 | -1.82 | -4.98 | -0.32 | -2.62 | -6.36 |
| Tax % | 28.57% | -11.57% | -3.77% | -4.87% | 19.05% | 0% | 0% | -0.46% | -0.55% | -0.2% | -3.12% | 14.5% | 0% |
| Net Profit | 0.21 | -1.89 | -4.58 | -3.32 | -0.5 | -11.6 | -4.66 | -4.32 | -1.82 | -4.97 | -0.32 | -3 | -6.36 |
| EPS in Rs | 0 | -0.04 | -0.11 | -0.08 | -0.01 | -0.27 | -0.11 | -0.1 | -0.04 | -0.12 | -0.01 | -0.07 | -0.15 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 183 | 158 | 195 | 158 | 156 | 153 | 288 | 163 | 15 | 0 | 0 | 0 |
| Expenses | 167 | 176 | 151 | 188 | 149 | 148 | 147 | 275 | 152 | 23 | 19 | 3 | 3 |
| Operating Profit | 8 | 7 | 6 | 8 | 9 | 8 | 6 | 13 | 11 | -8 | -19 | -3 | -3 |
| OPM % | 4.5% | 3.7% | 4% | 4% | 6% | 5% | 3.8% | 4.5% | 6% | -54% | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 3 | -6 | -3 |
| Interest | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 3 | 0 | 7 |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 1 | 1 | 1 | 3 | 4 | 4 | 1 | 8 | 5 | -10 | -21 | -10 | -14 |
| Tax % | -14% | 33% | 30% | 37% | 25% | 26% | 24% | 26% | 27% | -5% | 0% | 4% | — |
| Net Profit | 1 | 1 | 1 | 2 | 3 | 3 | 1 | 6 | 4 | -10 | -21 | -10 | -15 |
| EPS in Rs | 0.11 | 0.02 | 0.02 | 0.04 | 0.08 | 0.06 | 0.02 | 0.14 | 0.09 | -0.22 | -0.49 | -0.24 | -0.35 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 15 | 15 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 3 | 4 | 4 | 18 | 21 | 24 | 25 | 31 | 35 | 25 | 4 | -6 |
| Borrowings | 55 | 50 | 47 | 47 | 42 | 40 | 44 | 43 | 37 | 37 | 38 | 37 |
| Other Liabilities | 39 | 15 | 21 | 26 | 12 | 16 | 10 | 21 | 13 | 15 | 15 | 17 |
| Total Liabilities | 104 | 84 | 88 | 113 | 97 | 101 | 100 | 116 | 106 | 98 | 79 | 69 |
| Fixed Assets | 15 | 13 | 11 | 11 | 10 | 8 | 7 | 7 | 7 | 6 | 5 | 4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 89 | 71 | 76 | 102 | 87 | 92 | 93 | 109 | 99 | 93 | 74 | 65 |
| Total Assets | 104 | 84 | 88 | 113 | 97 | 101 | 100 | 116 | 106 | 98 | 79 | 69 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 9 | 1 | 6 | -14 | 8 | 5 | 1 | 36 | -20 | 1 | 2 | 1 |
| Investing | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 |
| Financing | -11 | -1 | -7 | 15 | -8 | -6 | -1 | -6 | -10 | -1 | -2 | -1 |
| Net Cash Flow | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | -31 | 0 | 0 | 0 |
| Free Cash Flow | 9 | 1 | 6 | -14 | 8 | 5 | 1 | 36 | -20 | 1 | 2 | 1 |
| CFO/OP | 119 | 23 | 108 | -171 | 114 | 77 | 32 | 287 | -194 | -7 | -11 | -32 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122 | 74 | 88 | 98 | 86 | 120 | 104 | 10 | 62 | 586 | — | — |
| Inventory Days | 65 | 66 | 90 | 95 | 121 | 99 | 121 | 85 | 96 | 678 | 340 | — |
| Days Payable | 63 | 28 | 49 | 46 | 27 | 36 | 23 | 25 | 20 | 184 | 203 | — |
| Cash Conversion Cycle | 123 | 112 | 128 | 147 | 180 | 183 | 202 | 70 | 138 | 1,080 | — | — |
| Working Capital Days | 104 | 109 | 53 | 85 | 100 | 108 | 119 | 31 | 127 | 1,249 | — | — |
| ROCE % | — | 8% | 7% | 8% | 9% | 8% | 6% | 14% | 10% | -10% | -24% | -6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shree Ram Proteins insights
54 extracted metrics + investor summaries across FY12–FY25.
Documents
1
Shareholders meeting
11 Sep - Postal ballot on August 11-September 9, 2026 approved sale, lease or disposal of the whole undertaking. 11 Sep - Postal ballot on August 11-September 9, 2026 approved sale, lease or disposal of the whole undertaking.
2
Outcome of Board Meeting
11 Sep - Board approved Q1 FY2026 unaudited and FY2026 audited results; auditors issued adverse opinion over going-concern risks. 11 Sep - Board approved Q1 FY2026 unaudited and FY2026 audited results; auditors issued adverse opinion over going-concern risks.
Frequently Asked Questions about Shree Ram Proteins
What does Shree Ram Proteins Ltd do?
Incorporated in 2008, Shree Ram Proteins Ltd is in the business of edible oil and solvent extraction from all types of agro[1]
Where is Shree Ram Proteins Ltd (SRPL) listed?
Shree Ram Proteins Ltd trades as SRPL on the NSE.
Which sector does Shree Ram Proteins Ltd belong to?
Shree Ram Proteins Ltd is classified under the Fast Moving Consumer Goods sector, in the Agricultural Food & other Products industry.
What is the market capitalisation of Shree Ram Proteins Ltd?
Shree Ram Proteins Ltd has a market capitalisation of ₹14.57 Cr, which places it in the Small Cap band.
What is the PE ratio of Shree Ram Proteins Ltd?
Shree Ram Proteins Ltd trades at a PE ratio of -0.60, against a book value of ₹0.87 per share.
What is the 52-week high and low of Shree Ram Proteins Ltd?
Over the last 52 weeks Shree Ram Proteins Ltd has traded between ₹0.32 and ₹0.84.
What is the Return on Equity (ROE) of Shree Ram Proteins Ltd?
Shree Ram Proteins Ltd reported a return on equity of -82.72%. Its debt-to-equity ratio is 2.47.
Company Information
Incorporated in 2008, Shree Ram Proteins Ltd is in the business of edible oil and solvent extraction from all types of agro[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SRPL.md for Shree Ram Proteins Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.